Tradestie Institutional Equity Comparison Engine · Market Close Jan 16, 2026

TEF vs MNMD: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

TEF Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 6–4 Matrix Metrics)

TEF Overall Winner 6-Pillar Tally: TEF 4 – 2 MNMD Matrix Metrics: TEF 6 – 4 MNMD

As of Jan 16, 2026, Telefonica, S.A. (TEF) is the stronger overall head-to-head candidate over Mind Medicine (MindMed) Inc. Common Shares (MNMD) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). TEF carries a Unified Composite Score of 56.8/100 (HOLD) at $3.81 (15.6x Forward P/E, 13.0% operating margin), whereas MNMD carries 63.1/100 (BUY) at $15.02 (N/M Forward P/E, 0.0% operating margin).

  • Composite vs. Pillar Nuance: While MNMD currently prints a higher short-term Unified Composite Score (63.1/100 BUY vs. TEF 56.8/100 HOLD), TEF captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (13.0% vs. 0.0% operating margin) and revenue trajectory (-6.6% vs. +0.0% YoY).
  • Technical & Structure Timing Caution: TEF is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.9); meanwhile MNMD trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 65.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About TEF vs MNMD
TEF NYSE Head-to-Head Winner
Telefonica, S.A.
Telephone Communications (No Radiotelephone)
$3.81
-1.04% 1D
Market Cap $21.5B
TTM Revenue $41.6B
Forward P/E 15.6x
Beta / 30D Vol 0.37β · 25% Vol
Unified Composite Score
56.8 / 100 HOLD
Tech 45.0 Fund 50.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.9%), weak momentum, RSI 37
RSI-14: 36.9 · SMA20: $3.96 · SMA50: $4.09
MNMD NASDAQ
Mind Medicine (MindMed) Inc. Common Shares
Medicinal Chemicals & Botanical Products
$15.02
+1.01% 1D
Market Cap $1.4B
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.79β · 55% Vol
Unified Composite Score
63.1 / 100 BUY
Tech 75.0 Fund 62.0 Flow 60.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.7% over 20 days), RSI 65
RSI-14: 65.3 · SMA20: $13.52 · SMA50: $12.57

6-Pillar Scorecard Institutional Category Breakdown (TEF 4 – 2 MNMD)

Columns: Metric · TEF · MNMD
1. Valuation Multiples TEF
Forward P/E 15.6x N/M
Trailing P/E 12.6x N/M
PEG Ratio 0.34x N/M
EV / Revenue 0.5x N/M
2. Growth & Scale MNMD
Revenue Growth (YoY) -6.6% +0.0%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) $41.6B N/A
Market Cap $21.5B $1.4B
3. Profitability & Quality TEF
Gross Margin 54.5% N/A
Operating Margin 13.0% 0.0%
Net Profit Margin -5.0% 0.0%
Return on Equity (ROE) -2.3% -85.6%
4. Balance Sheet & Cash Flow TEF
Cash Generation (TTM) $9.47B EBITDA N/A
Cash Flow Margin 22.8% EBITDA Mgn N/A
Net Cash / Leverage $3.63 Book/Sh · -2.3% ROE $1.70 Book/Sh · -85.6% ROE
Dividend Yield 9.15% None (0.00%)
5. Options & Positioning MNMD
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 40.4% (47th %ile) 70.7% (6th %ile)
Put/Call OI Skew Thin ADR Chain 0.18x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markup
6. R&D & Supply-Chain Moat TEF
OpEx & R&D Intensity 41.5% of Rev ($17.3B) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Telecom Services Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: TEF (6) vs MNMD (4)
Institutional Metric TEF MNMD Criterion Row Edge
Market Capitalization
Scale
$21.5B $1.4B Larger Scale TEF
Trailing P/E Ratio
Valuation
12.6x N/M Lower Multiple TEF
Forward P/E Ratio
Valuation
15.6x N/M Lower Multiple TEF
Revenue Growth (YoY)
Growth
-6.6% +0.0% Higher Growth MNMD
Operating Margin (TTM)
Profitability
13.0% 0.0% Higher Margin TEF
Net Profit Margin
Profitability
-5.0% 0.0% Higher Margin MNMD
Return on Equity (ROE)
Capital Efficiency
-2.3% -85.6% Higher ROE TEF
52-Week Range Position
Momentum
0% ($4–$6) 98% ($5–$15) Stronger Trend MNMD
Beta / 30D Volatility
Risk Regime
0.37β · 25% Vol 1.79β · 55% Vol Lower Realized Risk TEF
Unified Institutional Score
Composite Signal
56.8 / 100 (HOLD) 63.1 / 100 (BUY) Higher Composite MNMD
Trailing 12M Revenue (USD)
Operating Scale
$41.6B N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
54.5% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.34x PEG · 0.5x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$9.47B EBITDA ($3.63 Book/Sh · -2.3% ROE) N/A ($1.70 Book/Sh · -85.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MNMD +27.86 pp
TEF: -8.32% · MNMD: +19.54%
3M Horizon MNMD +41.29 pp
TEF: -22.27% · MNMD: +19.02%
6M Horizon MNMD +100.01 pp
TEF: -24.95% · MNMD: +75.06%
1Y Horizon MNMD +125.41 pp
TEF: -3.22% · MNMD: +122.19%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TEF vs MNMD. Trailing 12-month operating profitability (TEF 13.0% vs MNMD 0.0%) and valuation multiples (TEF 15.6x vs MNMD N/M Forward P/E) are benchmarked directly in Pillar 4 below.

TEF ADR TTM Benchmark FX-Normalized USD
TTM Revenue$41.6B
Gross Margin54.5%
Op. Margin13.0%
ROE / Fwd P/E-2.3% · 15.6x
MNMD ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-85.6% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
TEF UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 40.4%
IV Percentile 47th %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact TEF Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MNMD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 70.7%
IV Percentile 6th %ile
Put/Call OI Skew 0.18x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MNMD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
TEF Moat Profile Cyclical / Execution-Driven Positioning
Telecom Services Operator
Competes within the Telecom Services value chain with $21.5B market capitalization and 13.0% operating margin.
OpEx & R&D Reinvestment 41.5% of Rev ($17.3B)
90D Engineering Disclosures 0 Published
MNMD Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $1.4B market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ TEF vs MNMD Key Questions & Quantitative Answers

As of Jan 16, 2026, Telefonica, S.A. (TEF) is the stronger overall head-to-head candidate over Mind Medicine (MindMed) Inc. Common Shares (MNMD) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). TEF carries a Unified Composite Score of 56.8/100 (HOLD) at $3.81 (15.6x Forward P/E, 13.0% operating margin), whereas MNMD carries 63.1/100 (BUY) at $15.02 (N/M Forward P/E, 0.0% operating margin). Composite vs. Pillar Nuance: While MNMD currently prints a higher short-term Unified Composite Score (63.1/100 BUY vs. TEF 56.8/100 HOLD), TEF captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (13.0% vs. 0.0% operating margin) and revenue trajectory (-6.6% vs. +0.0% YoY). Technical & Structure Timing Caution: TEF is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.9); meanwhile MNMD trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 65.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

MNMD leads the Growth & Scale pillar: TEF posts -6.6% YoY revenue growth and N/A YoY earnings growth on $41.6B TTM revenue (54.5% gross margin, 13.0% operating margin), compared with MNMD at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, TEF generates $41.6B in USD-normalized revenue versus N/A for MNMD. In operating R&D and SG&A reinvestment, TEF deploys 41.5% of Rev ($17.3B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for MNMD.

TEF screens cheaper on headline valuation multiples. TEF trades at 15.6x Forward P/E, 12.6x Trailing P/E, 0.34x PEG, and 0.5x EV/Revenue (22.8% EBITDA margin), whereas MNMD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TEF (-2.3% ROE) versus MNMD (-85.6% ROE) capital efficiency.

In options market volatility and institutional positioning, TEF carries 40.4% implied volatility (47th %ile, Balanced (25th–60th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.37β · 25% Vol realized risk). By comparison, MNMD carries 70.7% implied volatility (6th %ile, Compressed (<25th %ile)), a 0.18x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.79β · 55% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Jan 16, 2026. For educational research only; not investment advice.